ADMA Biologics Announces Board Changes

ADMA Biologics, Inc. (NASDAQ:ADMA) recently reported significant changes within its Board of Directors. On November 19, 2024, Bryant E. Fong submitted his resignation as a member of the Board, effective immediately. This decision was made to allow Fong to allocate more time to his positions as the Managing Director of Biomark Capital Fund and as […]

Leave a Reply

Your email address will not be published.

Previous post StoneX Group Inc. Has $2.08 Million Position in Kinder Morgan, Inc. (NYSE:KMI)
Next post Centaurus Financial Inc. Has $5.87 Million Stock Holdings in Waste Connections, Inc. (NYSE:WCN)